Riluzole, an FDA-approved drug to treat ALS, can, in part, correct the molecular cause of some leukodystrophies.
Riluzole, a drug commonly prescribed to slow the progression of ALS, appears to slow brain metabolic decline and improve cognitive performance in those with mild Alzheimer's disease.
Image shows slices of a rat brain.
In animal studies, riluzole, a drug available for the treatment of ALS, has proven effective in preventing fading memories associated with old age, a new study reports.
Researchers propose improvements to how well ALS therapeutics work.
